Hunter, A. M., Padron, E.> ;Best practice & research. Clinical haematology. 2020 Oct 12
Abstracts/Posters
Impact of TP53 gene Mutation Clearance and Conditioning Intensity on Outcome in MDS or AML Patients Prior to Allogeneic Stem Cell Transplantation
Anthony Hunter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Patient Derived Xenografts (PDX) Recapitulate Ruxolitinib Clinical Trial Responses and Identify a Novel Combination Therapy for Chronic Myelomonocytic Leukemia (CMML)
Anthony M. Hunter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Effects of the Therapeutic Armamentarium on Survival and Time to Next Treatment in CMML Subtypes: An International Analysis of 950 Cases Coordinated By the AGMT Study ...
Anthony M. Hunter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Bone Marrow Mastocytosis Is Independently Associated with Inferior Survival in Chronic Myelomonocytic Leukemia
Anthony Hunter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019